Canary Regulatory Affairs

About Canary Regulatory Affairs

Canary Regulatory Affairs provides expert Product Development and Global Regulatory Affairs strategic advice and operational support to pharmaceutical, biotechnology, and medical device companies. Our mission is to expedite the registration and commercialization of our clients’ products, ensuring they can meet patient needs in a timely fashion. We partner with clients through every phase of the development journey, from concept to regulatory approval. As seasoned industry professionals, we understand the challenges our clients face and are committed to finding effective solutions. Our comprehensive expertise spans: • Quality: from formulation to manufacturing and process validation. • Non-Clinical: design and project management of in vitro and in vivo and toxicology studies. • Clinical: Protocol development, investigator brochure preparation, and clinical study report writing. Canary ensures seamless global product registration by fostering early dialogue with international regulatory authorities. With extensive experience working with the European Medicines Agency, National Competent Authorities in Europe, the U.S. FDA, and Australia’s TGA, we help our clients ask the right questions, overcome regulatory hurdles, and resolve challenges through skilled negotiation. Our belief in fostering constructive relationships with all stakeholders ensures smooth pathways to problem-solving. We work closely with clients to define clear objectives and create tailored strategies to achieve them within ambitious yet realistic timeframes. Recognizing that resources can be limited, we offer flexible support that integrates seamlessly with in-house teams. At Canary, we take pride in delivering high-quality, timely results, treating every client project with the same care and dedication as if it were our own.

View contact profiles from Canary Regulatory Affairs